E-LIB Suche - Ergebnisse für: Veit J. Erpenbeck

1

Prostaglandin D2 metabolites activate asthmatic patient-der..:

Carstensen, Saskia ; Gress, Christina ; Erpenbeck, Veit J....
Respiratory Research. 22 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

2

Increased type 2 inflammation post rhinovirus infection in ..:

Southworth, Thomas ; Pattwell, Caroline ; Khan, Naimat...
Cytokine. 125 (2020) - p. 154857 , 2020

Link: https://doi.org/10.1016/..

3

Fevipiprant, a selective prostaglandin D2 receptor 2 antago..:

Hardman, Clare ; Chen, Wentao ; Luo, Jian...
Journal of Allergy and Clinical Immunology. 143 (2019) 6 - p. 2329-2333 , 2019

Link: https://doi.org/10.1016/..

4

Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil..:

Shamri, Revital ; Dubois, Gerald ; Erpenbeck, Veit J....
Clinical & Experimental Allergy. 49 (2018) 2 - p. 255-257 , 2018

Link: https://doi.org/10.1111/..

5

The prostaglandin D2 receptor 2 pathway in asthma: a key pl..:

Domingo, Christian ; Palomares, Oscar ; Sandham, David A...
Respiratory Research. 19 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

6

U-BIOPRED: evaluation of the value of a public–private part..:

Riley, John H. ; Erpenbeck, Veit J. ; Matthews, John G....
Drug Discovery Today. 23 (2018) 9 - p. 1622-1634 , 2018

Link: https://doi.org/10.1016/..

7

Omalizumab normalizes the gene expression signature of lesi..:

Metz, Martin ; Torene, Rebecca ; Kaiser, Sergio...
Allergy. 74 (2018) 1 - p. 141-151 , 2018

Link: https://doi.org/10.1111/..

8

Clinical efficacy of omalizumab in chronic spontaneous urti..:

Metz, Martin ; Staubach, Petra ; Bauer, Andrea...
Theranostics. 7 (2017) 5 - p. 1266-1276 , 2017

Link: https://doi.org/10.7150/..

9

Pharmacokinetics, Safety, and Tolerability of Fevipiprant (..:

Erpenbeck, Veit J. ; Vets, Eva ; Gheyle, Lien...
Clinical Pharmacology in Drug Development. 5 (2016) 4 - p. 306-313 , 2016

Link: https://doi.org/10.1002/..

10

The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II ..:

Erpenbeck, Veit J. ; Popov, Todor A. ; Miller, David...
Pulmonary Pharmacology & Therapeutics. 39 (2016) - p. 54-63 , 2016

Link: https://doi.org/10.1016/..

11

Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in p..:

Erpenbeck, Veit J. ; Popov, Todor A. ; Miller, David...
Data in Brief. 9 (2016) - p. 199-205 , 2016

Link: https://doi.org/10.1016/..

12

Exacerbation of atopic dermatitis on grass pollen exposure ..:

Werfel, Thomas ; Heratizadeh, Annice ; Niebuhr, Margarete...
Journal of Allergy and Clinical Immunology. 136 (2015) 1 - p. 96-103.e9 , 2015

Link: https://doi.org/10.1016/..

13

Cell Counting in Human Endobronchial Biopsies - Disagreemen..:

Bratu, Vlad A. ; Erpenbeck, Veit J. ; Fehrenbach, Antonia...
PLoS ONE. 9 (2014) 3 - p. e92510 , 2014

Link: https://doi.org/10.1371/..

14

Omalizumab in patients with allergic (IgE-mediated) asthma ..:

Kornmann, Oliver ; Watz, Henrik ; Fuhr, Rainard...
Pulmonary Pharmacology & Therapeutics. 28 (2014) 2 - p. 149-153 , 2014

Link: https://doi.org/10.1016/..

15

Omalizumab in the treatment of severe allergic (IgE‐mediate..:

Humbert, Marc ; Canvin, Janice ; Kiechle, Tamara..
Clinical and Translational Allergy. 3 (2013) S1 - p. , 2013

Link: https://doi.org/10.1186/..